Liver parenchymal damage and inflammation pathways

Liver parenchymal damage and inflammation pathways represent the integrated molecular cascades that drive hepatic injury and subsequent immune responses [PubMed: PMC4865532]. These pathways are initiated by various stressors, including metabolic overload, viral infection, or toxic insult, which lead to hepatocyte apoptosis or necrosis [NIH: Liver Cirrhosis]. The resulting release of damage-associated molecular patterns (DAMPs) activates resident Kupffer cells and recruits circulating inflammatory cells through pattern recognition receptors like TLR4 [Nature Reviews Gastroenterology & Hepatology, 2016]. This activation triggers the production of pro-inflammatory cytokines, such as TNF-α and IL-6, which further exacerbate tissue damage and can lead to chronic inflammation [StatPearls: Liver Inflammation]. Over time, persistent inflammatory signaling promotes the activation of hepatic stellate cells, leading to collagen deposition and fibrosis [PubMed: PMC7073934]. Therapeutic strategies targeting these pathways often involve the use of anti-inflammatory agents, antioxidants, or metabolic modulators to prevent the progression to cirrhosis or liver failure [PubChem]. Understanding the crosstalk between parenchymal cells and the immune system is essential for identifying specific therapeutic nodes within these broad pathways.

Other names

Hepatic inflammation and injuryHepatocyte damage pathwaysLiver injury cascadesHepatic parenchymal damage

Inhibition of pro-inflammatory cytokine signaling, reduction of oxidative stress, and modulation of metabolic pathways to prevent hepatocyte death.